Mylan could be trying to pump up it's image.... but..... right now we have Epi-pen brand auto injectors. To replace them means that we will be replacing them not with Mylan epipens though. Our insurance no longer covers them, or their generics.
So, how much business are they going to lose if you combined people getting auvi-q and those of us who will be bumped over to the CVS auto-injectors?
I guess I don't necessarily know if it makes sense for their bottom line to widen a recall if it isn't absolutely necessary because in the one year-ish time span Epipens last, insurance companies are dumping them and two other options are out and theoretically covered.
How many people will really be replacing their recalled Mylan Epipens with Mylan Epipens?